ONCOTYPE DX provides the information using tumor section and predicts locoregional disease recurrence that helps in making decision about the radiotherapy for postmenopausal women with ER/PR positive and node positive breast cancer [95, 96]. The gene discussed is ESR1; the disease is neoplasm.